Quick Detail
Place of Origin
Brand Name
Jinlan
HS-CODE
-
Package & Delivery Lead Time
Package
1g,10g,20g,
Detailed Description
Description
Apalutamide is an oral, selective, competitive androgen receptor (AR) inhibitor that blocks androgen binding, nuclear translocation, and AR-mediated transcription, thereby inhibiting prostate cancer cell proliferation.
Approved Indications
- Non-metastatic castration-resistant prostate cancer (NM-CRPC)
- Metastatic castration-sensitive prostate cancer (mCSPC)
Key Features
- High potency and selectivity for AR
- Low central nervous system penetration
- Oral once-daily dosing
- Established overall survival benefit in prostate cancer
Applications
API, intermediates, reference standards for R&D, generic registration and commercial manufacturing.
China [CN] 
Click enlarge Image